SCHEMBL6239428

SCHEMBL6239428

O=C(CBr)NC1=C(Cl)C(=O)c2ccccc2C1=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HKDC1 Q2TB90 3/20 0.68
TLR9 Q9NR96 2/20 0.68
TDP2 O95551 1/20 0.68
PAX8 Q06710 1/20 0.68
HSP90AA1 P07900 3/20 0.64
HSP90AB1 P08238 2/20 0.64
CDC25A P30304 7/20 0.56
CDC25B P30305 4/20 0.54
MAPT P10636 7/20 0.53
HTT P42858 7/20 0.53
LMNA P02545 5/20 0.53
ALDH1A1 P00352 4/20 0.53
MITF O75030 3/20 0.53
USP2 O75604 1/20 0.53
POLB P06746 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
RAB9A P51151 4/20 0.52
NPSR1 Q6W5P4 4/20 0.52
L3MBTL1 Q9Y468 3/20 0.52
ATM Q13315 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10891344 0.85 HKDC1 (0.70) HKDC1TLR9TDP2PAX8HSP90AA1
SCHEMBL6240574 0.85 TDP2 (0.55) HKDC1TLR9TDP2PAX8HSP90AA1
SCHEMBL7957003 0.84 HKDC1 (0.78) HKDC1TLR9TDP2PAX8HSP90AA1
SCHEMBL7955400 0.81 TDP2 (1.00) HKDC1TLR9TDP2PAX8HSP90AA1
SCHEMBL6239508 0.79 TDP2 (0.48) HKDC1TLR9TDP2PAX8HSP90AA1
SCHEMBL6190569 0.78 HSP90AA1 (1.00) HKDC1TLR9TDP2PAX8HSP90AA1
SCHEMBL31087717 0.78 HSP90AA1 (1.00) HKDC1TLR9TDP2PAX8HSP90AA1
SCHEMBL7961611 0.77 TDP2 (0.59) HKDC1TLR9TDP2PAX8HSP90AA1
SCHEMBL134428 0.77 HSP90AA1 (0.68) HKDC1TLR9TDP2PAX8HSP90AA1
SCHEMBL31162649 0.77 HSP90AA1 (0.68) HKDC1TLR9TDP2PAX8HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005016000-A1 DERIVATIVES OF CYCLIC QUINONE AND USES THEREOF AVALON PHARMACEUTICALS (US) 2005-02-24 WO disclosed
US-20050032794-A1 Diamine derivatives of quinone and uses thereof CLINICAL DATA, INC. 2005-02-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032794-A1 Diamine derivatives of quinone and uses thereof NQO1, DPYD, NQO2 HKDC1 775/4885TLR9 2263/4885TDP2 833/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.